Post by Coultreon Biopharma

3,299 followers

Today marks an important moment for our company! With the successful completion of a $125 million Series A financing, we are entering a new chapter and doing so under a new name: Coultreon Biopharma. We are grateful for the trust and support of the group of new investors: Sofinnova Investments, Forbion, Novo Holdings, Galapagos, Regeneron Ventures, Balyasny Asset Management L.P., Luma Group, Samsara BioCapital, Longwood Fund and Finchley Healthcare Ventures.  We look forward to building the next phase together with our exceptional team! Read the full announcement here: https://lnkd.in/eNmS3MU2

Post content

Video Content